Johnson & Johnson (JNJ) has a new pill on the market for an illness called psoriasis, and Bank of America...
JampJ
Johnson & Johnson (JNJ) spent 2025 proving it could lose a multibillion-dollar drug and still grow. Now it wants to...
Global trade, energy transition, financial regulation, multinational corporations, and macroeconomic trends.
Johnson & Johnson (JNJ) has a new pill on the market for an illness called psoriasis, and Bank of America...
Johnson & Johnson (JNJ) spent 2025 proving it could lose a multibillion-dollar drug and still grow. Now it wants to...